eISSN: 2720-5371
ISSN: 1230-2813
Advances in Psychiatry and Neurology/Postępy Psychiatrii i Neurologii
Current issue Archive Manuscripts accepted About the journal Scientific board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
 
2/2022
vol. 31
 
Share:
Share:
more
 
 
abstract:
Review article

Stroke in the COVID-19 pandemic era

Małgorzata Wiszniewska
1, 2
,
Małgorzata Sankowska
3

1.
Emergency Medical Services, University of Applied Sciences, Piła, Poland
2.
Neurological Department with Stroke Unit, Specialist Hospital, Piła, Poland
3.
Central Clinical Hospital of Medical University of Warsaw, Poland
Adv Psychiatry Neurol 2022; 31 (2): 69-73
Online publish date: 2022/06/01
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Purpose
The aim of this article is to outline the impact of COVID-19 on the frequency of occurrence, course of stroke treatment, and to highlight the cause-effect relationship between SARS-CoV-2 infection and stroke on the basis of a literature overview.

Views
Since the end of 2019, the whole world has been struggling with the effects of the pandemic caused by the coronavirus SARS-CoV-2. The virus induces a wide spectrum of symptoms, ranging from mild or serious ones, which may lead to a severe multiorgan failure. Acute ischaemic stroke (AIS) might be associated with COVID-19 as a potentially fatal complication, while hemorrhagic stroke is less frequent. In most cases, stroke is caused by large artery occlusion. One of its reasons is hypercoagulation with a complex mechanism, which has not been fully explained. Research has shown that during COVID-19 pandemic, the number of patients admitted to hospitals due to AIS decreased. During the first pandemic wave there was no change regarding the proportion of patients with cerebral vessel obstruction who received endovascular treatment.

Conclusions
In the COVID-19 pandemic era, rapid intravenous administration of tissue plasminogen activator remains the main treatment for acute ischaemic stroke. Patients often fail to report to hospital for the fear of SARS-CoV-2 infection. It is of the utmost importance to raise society’s awareness of the necessity to report to hospital when experiencing serious symptoms, including stroke.

keywords:

stroke, coagulopathy, COVID-19, SARS-CoV-2

Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.